IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

RINALDI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.890
EU - Europa 6.887
AS - Asia 2.987
SA - Sud America 1.034
AF - Africa 484
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 18.291
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.676
RU - Federazione Russa 5.476
SG - Singapore 1.457
BR - Brasile 798
CN - Cina 418
FR - Francia 368
CI - Costa d'Avorio 339
VN - Vietnam 313
DE - Germania 275
IT - Italia 209
HK - Hong Kong 181
IN - India 139
GB - Regno Unito 131
CA - Canada 106
AR - Argentina 88
BD - Bangladesh 82
MX - Messico 69
PL - Polonia 68
NL - Olanda 62
IQ - Iraq 58
ZA - Sudafrica 55
TR - Turchia 45
JP - Giappone 39
ES - Italia 36
ID - Indonesia 36
AT - Austria 34
PK - Pakistan 34
CZ - Repubblica Ceca 32
LT - Lituania 32
EC - Ecuador 29
IE - Irlanda 29
CO - Colombia 28
FI - Finlandia 28
SA - Arabia Saudita 27
UA - Ucraina 27
MA - Marocco 26
SE - Svezia 26
VE - Venezuela 23
EG - Egitto 19
UZ - Uzbekistan 19
PH - Filippine 18
CL - Cile 17
AE - Emirati Arabi Uniti 16
MY - Malesia 14
PY - Paraguay 14
UY - Uruguay 13
PE - Perù 12
NP - Nepal 11
BE - Belgio 9
BO - Bolivia 9
JO - Giordania 9
TH - Thailandia 9
DZ - Algeria 7
HN - Honduras 7
JM - Giamaica 7
RO - Romania 7
AU - Australia 6
AZ - Azerbaigian 6
ET - Etiopia 6
KE - Kenya 6
KZ - Kazakistan 6
OM - Oman 6
TN - Tunisia 6
AM - Armenia 5
BG - Bulgaria 5
BY - Bielorussia 5
IL - Israele 5
KR - Corea 5
KW - Kuwait 5
PA - Panama 5
PT - Portogallo 5
SN - Senegal 5
CR - Costa Rica 4
BB - Barbados 3
DO - Repubblica Dominicana 3
GA - Gabon 3
HR - Croazia 3
HU - Ungheria 3
LV - Lettonia 3
LY - Libia 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BZ - Belize 2
CG - Congo 2
CH - Svizzera 2
EE - Estonia 2
GY - Guiana 2
IR - Iran 2
LB - Libano 2
LU - Lussemburgo 2
MN - Mongolia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TW - Taiwan 2
Totale 18.272
Salva come PNG Salva come JPEG
Città #
Dallas 2.634
Moscow 1.821
San Jose 1.460
Ashburn 660
Singapore 599
The Dalles 369
Abidjan 339
Lauterbourg 252
Frankfurt am Main 177
Hong Kong 176
New York 170
Beijing 158
Ho Chi Minh City 119
Los Angeles 118
São Paulo 82
Warsaw 59
Hanoi 57
Chennai 54
Amsterdam 50
Santa Clara 49
Boardman 47
Orem 45
Brooklyn 43
Nuremberg 43
Denver 41
Tokyo 39
Montreal 38
London 36
Chicago 31
Assago 30
Munich 30
Boston 28
Johannesburg 28
Dublin 27
Brno 26
Phoenix 26
Stockholm 26
Rio de Janeiro 24
San Francisco 24
Hillsboro 23
Toronto 23
Baghdad 22
Atlanta 21
Mumbai 20
Council Bluffs 19
Mexico City 19
Lahore 18
Poplar 18
Tashkent 18
Belo Horizonte 17
Da Nang 17
Manchester 17
Ankara 16
Brasília 15
Columbus 15
Haiphong 14
Houston 14
West Jordan 14
Guarulhos 13
Naples 13
Querétaro 13
Campobasso 12
Curitiba 12
Helsinki 12
Montevideo 12
Ottawa 12
Rome 12
Charlotte 11
Jakarta 11
New Delhi 11
Volta Redonda 11
Cape Town 10
Caracas 10
Dhaka 10
Falkenstein 10
Goiânia 10
Jeddah 10
Medellín 10
Quito 10
Brussels 9
Casablanca 9
Córdoba 9
Erbil 9
Vienna 9
Guayaquil 8
Ha Long 8
Lappeenranta 8
Milan 8
Ribeirão Preto 8
Riyadh 8
Roubaix 8
Santiago 8
Santo André 8
São Bernardo do Campo 8
Terzigno 8
Amman 7
Kuala Lumpur 7
Lima 7
Limburg an der Lahn 7
Porto Alegre 7
Totale 10.778
Salva come PNG Salva come JPEG
Nome #
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 614
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 533
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study 142
A genic and epigenetic combination therapy for liver cancer 137
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions 136
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 134
A suspected infective endocarditis in patients with a history of chronic HCV infection 127
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 125
[Inhibitors of intra-cystic secretion: novel therapies in ADPKD (Autosomal Dominant Polycystic Kidney Disease)] 124
Adherence to AISF recommendations for integrated management of hepatocellular carcinoma in a real–world clinical practice 124
A gene and epigenetic combination therapy for liver cancer treatment 121
Angiogenesis inhibitors for the treatment of hepatocellular carcinoma 121
Advances in Nanomedicine for Precision Insulin Delivery 121
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 119
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 117
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 117
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 117
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 115
. Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics 114
[Next Generation Sequencing and ADPKD] 113
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 112
A Controversial Case of a Double Hepatic Incidentaloma in a Male Patient with Kidney Failure 112
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 112
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 111
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 111
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 109
An atypical resentation of a parasitic infection, simulating abdominal expansive mass: a multidisciplinary case report 107
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 107
Antibiotic use and associated factors in a large sample of hospitalised older people 107
A clear case of portal hypertension: a logical consequence of liver cirrhosis? 106
An atypical presentation of a rare parasitic infection of Fasciola hepatica: a multidisciplinary case report. 106
Oxidative Stress and Cardiovascular Complications in Type 2 Diabetes: From Pathophysiology to Lifestyle Modifications 105
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 103
Adherence to Barcelona Clinic Liver Cancer guidelines in field-practice: results of Progetto Epatocarcinoma Campania 103
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 102
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 99
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 98
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 96
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 95
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 95
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis 94
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 89
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 89
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 88
Cardiovascular benefits from gliflozins: Effects on endothelial function 83
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 81
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease 80
What changed in the Italian internal medicine and geriatric wards during the lockdown 76
Steatosis is a determinant of fibrosis progression in chronic hepatitis C and is correlated both with body composition and viral factors 76
Hepatocellular carcinoma and non alcoholic fatty liver disease; a dangerous liaison 76
Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations 76
HCV-related steatosis and risk of atherosclerosis 76
Neurophysiological assessment of peripheral neuropathy through whole plantar nerve conduction in type 2 diabetes mellitus and healthy control subjects 75
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 74
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 72
Liver fibrosis by FibroScan is highly prevalent in type 2 diabetic patients with NAFLD and fairly normal liver enzymes but increased uric acid 71
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 69
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 69
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 68
Features of microvessel density (MVD) and angiogenesis inhibitors in therapeutic approach of hepatocellular carcinoma (HCC) 68
Sonoporation by microbubbles as gene therapy approach for liver cancer 68
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 68
Epigenetic and Genetic Keys to Fight HPV-Related Cancers 67
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 67
Cryptogenic cirrhosis is associated with cardiometabolic and oncologic comorbidities and poor liver-related prognosis 65
Late HCC onset after direct antiviral agents therapy in patients with sustained virological response: do we need to reconsider their efficacy according to long term follow-up? 64
Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects 64
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 63
Early changes of liver stiffness in HCV patients undergoing treatment with direct-acting antivirals (DDAs): a multicenter study 63
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 63
Hepatitis C virus eradication by direct antiviral agents improves carotid atherosclerosis in patients with advanced fibrosis/compensated cirrhosis 63
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 63
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 62
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 62
Influence of antiviral therapy on liver stiffness evaluation in chronic hepatitis HBV patients in a real world setting: preliminary data in a multicentric study 61
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 60
Twelve-week course of pIFN-a-2a/ribavirin is an optimized regimen for treatment of HCV genotype 2 but not genotype 3 non-cirrhotic patients with RVR 60
HCC recurrence after DAA treatment in HCV patients 60
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 59
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 59
Lactate in pleural and abdominal effusions 59
The importance of the thick ascending limb of Henle's loop in renal physiology and pathophysiology 59
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study. Authors’ reply 59
Role of tight glycemic control during acute coronary syndrome on CV outcome in type 2 diabetes 58
Characteristics and outcome of cryptogenic cirrhosis in Italy 58
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 58
Metabolic and renal changes in chronic hepatitis C patients after HCV clearance by direct-acting antivirals 58
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 58
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 58
HCV-related steatosis and risk of atherosclerosis 58
Hepatocellular carcinoma in patients with cryptogenic and metabolic cirrhosis: incidence, characteristics, risk factors and survival 58
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 57
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 57
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 57
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 57
Insulin resistance and cancer: molecular links and clinical perspectives 57
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 57
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 57
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 56
Editorial: Tissue resonance interaction method: a challenge for the early and non-invasive diagnosis of solid cancers 56
Totale 9.430
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024334 0 0 0 0 2 151 11 44 5 17 20 84
2024/20253.369 520 223 254 23 416 66 112 121 453 74 490 617
2025/202614.636 530 1.404 1.774 735 3.353 3.104 1.682 639 508 907 0 0
Totale 18.339